Evidence-Based Oncology is an important forum to have conversations that are needed in medicine today, said Joseph Alvarnas, MD, the new editor-in-chief of the journal.
Evidence-Based Oncology is an important forum to have conversations that are needed in medicine today, said Joseph Alvarnas, MD, the new editor-in-chief of the journal.
Physicians, nurses, payers, health systems, economists, and others have all existed in their own realms, he explained.
"The only to make the system work in ways which add value to our experience of care and care delivery is for us to break out of these silos and have honest conversations," Dr Alvarnas said.
See the latest issue of Evidence-Based Oncology here.
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
FDA Approves Tislelizumab for Advanced or Metastatic ESCC After Chemotherapy
March 15th 2024The FDA has approved tislelizumab-jsgr (Tevimbra) for single-agent use in adult patients with unresectable or metastatic esophageal squamous cell carcinoma following prior systemic chemotherapy that did not include a PD-1/PD-L1 inhibitor.
Read More
Navigating the Mental Health Challenges of Cancer Diagnosis, Treatment, and Survivorship
March 12th 2024Stress has potential links to worse outcomes in cancer, such as decreased quality of life and greater risks of disease progression and metastasis. There is a complex mix of emotions patients with cancer experience.
Read More